| Serial Number | 97524671 |
| Word Mark | ZEPHYR AI |
| Filing Date | Thursday, July 28, 2022 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Friday, May 3, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, September 26, 2023 |
| Goods and Services | Downloadable computer programs using artificial intelligence for machine learning; downloadable software using artificial intelligence for machine learning for scientific and medical research and development; downloadable computer software, software platforms, downloadable mobile applications, and downloadable software programs using artificial intelligence and machine learning technologies for scientific and medical research and development; downloadable computer programs using artificial intelligence for machine learning in the fields of healthcare, medicine, genetics, oncology, biology, life sciences, biotechnology, drug development, and pharmaceuticals |
| Goods and Services | Healthcare;medical services;consulting services in the field of healthcare, medicine, and medical use of pharmaceuticals; healthcare, medical, and pharmaceutical medical use information services; DNA screening for medical purposes; clinical medical consultation services; healthcare, medical, and pharmaceutical services, namely, providing databases in the fields of medical, scientific, genetic, oncological, and biological information for inputting, collecting, analyzing, and managing data for treatment and diagnostic purposes; healthcare and medical services, namely, analyzing medical, genetic, oncological, biological and diabetes-related data for treatment and diagnostic purposes by using machine learning and artificial intelligence technologies; providing medical consulting services in the fields of healthcare, medicine, genetics, oncology, biology, life sciences, biotechnology, drug development, and pharmaceuticals by using machine learning, artificial intelligence technology, and biotechnology |
| NOT AVAILABLE | "AI" |
| Goods and Services | Scientific research consulting services in the fields of healthcare, medicine, genetics, oncology, diabetes, biology, life sciences, biotechnology, drug development, and pharmaceuticals; scientific and medical research analysis of healthcare, medical, genetic, scientific, biologic, clinical and oncologic data; scientific research consulting in the fields of healthcare, medicine, genetics, oncology, diabetes, biology, life sciences, biotechnology, drug development, and pharmaceuticals; genetic and tumor mapping for scientific and medical research purposes; providing medical and scientific research information in the fields of genetics, oncology, diabetes, biology, life sciences, biotechnology, drug development, and pharmaceuticals; drug discovery services; scientific services, namely, analyzing medical, genetic, oncological, biological and diabetes-related data for treatment and diagnostic purposes by using machine learning and artificial intelligence technologies; providing scientific, medical and clinical research and scientific, medical and clinical research consulting services in the fields of healthcare, medicine, genetics, oncology, biology, life sciences, biotechnology, drug development, and pharmaceuticals by using machine learning, artificial intelligence technology, and biotechnology; medical and scientific research and consulting, namely, designing and organizing clinical trials for others; research and development services in the creation of databases and collections of information and data on biologicals for research purposes; providing genetic reference databases being collections of gene sequences for research purposes; disease modeling for research purposes; scientific analysis services, namely, services using computer algorithms for analysis of bioinformatics data in the field of research and development of therapeutic biomolecules for the treatment of cancer, diabetes, and other diseases; pharmaceutical drug development services; genetic research for identifying biomarker rankings for medical purposes; research and development of pharmaceutical preparations and medicines; consulting services in the field of pharmaceutical research and development; medical and scientific research in the field of medical treatment and diagnosis, including for cancer and diabetes; providing temporary use of online non-downloadable software, cloud-based software, platform as a service (PAAS) featuring computer software platforms, and a website featuring technology, all for enabling users to use artificial intelligence for machine learning in the fields of healthcare, medicine, genetics, oncology, diabetes, biology, life sciences, biotechnology, drug development, and pharmaceuticals; software design and development; software installation and maintenance; DNA analysis services for scientific and medical research purposes; application service provider (ASP) featuring software using artificial intelligence for machine learning |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, August 1, 2022 |
| Primary Code | 009 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, August 1, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, August 1, 2022 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Zephyr AI, Inc |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Dallas, TX 75219 |
| Party Name | Zephyr AI, Inc |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Dallas, TX 75219 |
| Event Date | Event Description |
| Monday, August 1, 2022 | NEW APPLICATION ENTERED |
| Monday, August 1, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, May 15, 2023 | ASSIGNED TO EXAMINER |
| Wednesday, May 17, 2023 | NON-FINAL ACTION WRITTEN |
| Wednesday, May 17, 2023 | NON-FINAL ACTION E-MAILED |
| Wednesday, May 17, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, June 13, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, June 13, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, June 14, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, August 22, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, August 14, 2023 | FINAL REFUSAL WRITTEN |
| Monday, August 14, 2023 | FINAL REFUSAL E-MAILED |
| Monday, August 14, 2023 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Tuesday, August 22, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, August 22, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, August 22, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, August 22, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, September 6, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, September 26, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, September 26, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Thursday, February 22, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, November 21, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, February 22, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, February 22, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, February 22, 2024 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Friday, May 3, 2024 | SOU TEAS EXTENSION RECEIVED |
| Friday, May 3, 2024 | SOU EXTENSION 1 FILED |
| Friday, May 3, 2024 | SOU EXTENSION 1 GRANTED |
| Saturday, May 4, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |